M
$ Value
$0
Shares
3,166
Price
$0
Filed
Mar 31
Insider
Name
KANTOFF AARON
Title
—
CIK
0001862734
Roles
Director
Transaction Details
Transaction Date
2026-03-28
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
3,167
Footnotes
Restricted stock units convert into common stock on a one-for-one basis. | On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Filing Info
KANTOFF AARON's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-28 | AVTX | M | — |
| 2026-03-28 | AVTX | M | $0 |
| 2025-09-05 | TRML | M | $5K |
| 2025-09-05 | TRML | M | $95K |
| 2025-09-05 | TRML | M | $0 |
| 2025-09-05 | TRML | M | $0 |
| 2025-06-17 | AVTX | A | $0 |
| 2025-06-04 | TRML | A | $0 |
Other Insiders at AVTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| KAPLAN GILLA | — | — | 2026-03-28 |
|
NEIL GARRY ARTHUR
Chief Executive Officer
|
— | — | 2026-03-28 |
| Lind Kevin Robert | — | — | 2026-03-31 |
| Jain Rita | — | — | 2026-03-31 |
| Chan Mitchell | — | — | 2026-03-28 |
|
Sullivan Christopher Ryan
Chief Financial Officer
|
— | $271K | 2026-04-02 |
| KANTOFF AARON | — | — | 2026-03-28 |
|
Doyle Mittie
Chief Medical Officer
|
— | $82K | 2026-04-06 |
| Goldman Jonathan | — | — | 2026-03-28 |
| Truex Samantha | — | — | 2026-03-28 |